A Prospective Phase I/II Study to Evaluate the Safety and Exploratory Efficacy of Three Intra-articular Injections of Ampion(TM) (4 ML) Administered Two Weeks Apart in Adults With Pain Due to Osteoarthritis of the Knee

Trial Profile

A Prospective Phase I/II Study to Evaluate the Safety and Exploratory Efficacy of Three Intra-articular Injections of Ampion(TM) (4 ML) Administered Two Weeks Apart in Adults With Pain Due to Osteoarthritis of the Knee

Completed
Phase of Trial: Phase I/II

Latest Information Update: 26 Mar 2018

At a glance

  • Drugs DMI 9523 (Primary)
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Acronyms STRUT
  • Sponsors Ampio Pharmaceuticals
  • Most Recent Events

    • 26 Mar 2018 According to an Ampio Pharmaceuticals media release, a partial follow up results (3.4-3.7 years) from this study will be presented at a peer-reviewed publication.
    • 26 Mar 2018 Results presented in an Ampio Pharmaceuticals media release
    • 16 Jan 2018 Detailed results of this study were published in journal Orthopedics in 2017, as reported in an Ampio Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top